Detalhe da pesquisa
1.
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.
Mult Scler
; 26(8): 912-923, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31066634
2.
Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing-remitting multiple sclerosis.
Eur J Neurol
; 26(6): 865-871, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30614590
3.
Cerebrospinal fluid:serum glucose ratio in the ventricular and lumbar compartments: implications for clinical practice.
Eur J Neurol
; 25(2): 373-379, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29115000
4.
Quantitation of intrathecal immunoglobulin synthesis - a new empirical formula.
Eur J Neurol
; 23(4): 713-21, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26806360
5.
Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium.
Clin Exp Immunol
; 181(3): 385-400, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-25959571
6.
Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2.
Eur J Neurol
; 27(9): 1754-1756, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32531083
7.
Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis.
Neuroradiology
; 57(12): 1203-9, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26293130
8.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Mult Scler
; 20(5): 577-87, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24009164
9.
Olfactory threshold is impaired in early, active multiple sclerosis.
Mult Scler
; 17(8): 964-9, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21372115
10.
Decision-making for and impact of early immunomodulatory treatment: the Austrian Clinically Isolated Syndrome Study (ACISS).
Eur J Neurol
; 17(6): 852-60, 2010 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20100231
11.
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.
Brain
; 132(Pt 12): 3353-65, 2009 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-19741051
12.
EFNS guidelines on disease-specific CSF investigations.
Eur J Neurol
; 16(6): 760-70, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19475759
13.
MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients.
Eur J Neurol
; 15(8): 822-6, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18549400
14.
Combined evaluation of personality, risk and coping in MS patients: A step towards individualized treatment choice - The PeRiCoMS-Study I.
J Neurol Sci
; 376: 71-75, 2017 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28431632
15.
Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
J Neuroimmunol
; 174(1-2): 174-9, 2006 May.
Artigo
Inglês
| MEDLINE | ID: mdl-16556466
16.
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force.
Eur J Neurol
; 13(9): 913-22, 2006 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-16930354
17.
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
Mult Scler
; 16(2): 129-32, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20042453
18.
Immunoglobulin subclasses in patients with neutralizing and nonneutralizing antibodies against IFN-beta1b.
J Interferon Cytokine Res
; 21(3): 167-71, 2001 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11331039
19.
Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies.
Neurology
; 52(6): 1239-43, 1999 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-10214750
20.
A comparative study of the relative bioavailability of different interferon beta preparations.
Neurology
; 54(11): 2055-60, 2000 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-10851362